SAMPLE_NAME	GENE	TYPE	SAMPLE_IMPACT	DB_IMPACT	DB_DRIVER_FREQUENCY	DB_MUTATION_FREQUENCY	CANCER_CENSUS	GDSC_DRUGS	ANNOTATIONS	ANNOTATIONS_P_VALUES
TCGA-02-0003-01A	CDK4	AMPL	69.635	0.000	0.000	0.016	Y	SB 216763[http://www.cancerrxgene.org/translation/Drug/1025],Vorinostat[http://www.cancerrxgene.org/translation/Drug/1012]	KEGG_P53_SIGNALING_PATHWAY	(0.0000001604774957661480876)
TCGA-02-0003-01A	TP53	MUT	69.635	1522.436	0.536	0.536	Y	Nutlin-3a[http://www.cancerrxgene.org/translation/Drug/1047],Thapsigargin[http://www.cancerrxgene.org/translation/Drug/180],Obatoclax Mesylate[http://www.cancerrxgene.org/translation/Drug/182],AZD-2281[http://www.cancerrxgene.org/translation/Drug/1017],AKT inhibitor VIII[http://www.cancerrxgene.org/translation/Drug/171]	KEGG_P53_SIGNALING_PATHWAY	(0.0000001604774957661480876)
TCGA-02-0003-01A	GLI1	AMPL	69.635	76.623	0.024	0.032	N	N/A	KEGG_P53_SIGNALING_PATHWAY	(0.0000001604774957661480876)
TCGA-02-0033-01A	PIK3CA	MUT	65.461	742.320	0.264	0.264	Y	AZD6482[http://www.cancerrxgene.org/translation/Drug/156],AKT inhibitor VIII[http://www.cancerrxgene.org/translation/Drug/171],PAC-1[http://www.cancerrxgene.org/translation/Drug/175],Pazopanib[http://www.cancerrxgene.org/translation/Drug/199],GW 441756[http://www.cancerrxgene.org/translation/Drug/1023],SB 216763[http://www.cancerrxgene.org/translation/Drug/1025]	KEGG_P53_SIGNALING_PATHWAY	(0.0035590909667369149092797)
TCGA-02-0033-01A	RB1	MUT	65.461	652.368	0.224	0.224	Y	PD-0332991[http://www.cancerrxgene.org/translation/Drug/1054],Nutlin-3a[http://www.cancerrxgene.org/translation/Drug/1047]	KEGG_P53_SIGNALING_PATHWAY	(0.0035590909667369149092797)
TCGA-02-0033-01A	TP53	MUT	65.461	1522.436	0.536	0.536	Y	Nutlin-3a[http://www.cancerrxgene.org/translation/Drug/1047],Thapsigargin[http://www.cancerrxgene.org/translation/Drug/180],Obatoclax Mesylate[http://www.cancerrxgene.org/translation/Drug/182],AZD-2281[http://www.cancerrxgene.org/translation/Drug/1017],AKT inhibitor VIII[http://www.cancerrxgene.org/translation/Drug/171]	KEGG_P53_SIGNALING_PATHWAY	(0.0035590909667369149092797)
TCGA-02-0047-01A	CREBBP	MUT	52.807	387.435	0.160	0.176	Y	N/A	N/A	N/A
TCGA-02-0047-01A	PIK3CA	MUT	52.807	742.320	0.264	0.264	Y	AZD6482[http://www.cancerrxgene.org/translation/Drug/156],AKT inhibitor VIII[http://www.cancerrxgene.org/translation/Drug/171],PAC-1[http://www.cancerrxgene.org/translation/Drug/175],Pazopanib[http://www.cancerrxgene.org/translation/Drug/199],GW 441756[http://www.cancerrxgene.org/translation/Drug/1023],SB 216763[http://www.cancerrxgene.org/translation/Drug/1025]	N/A	N/A
TCGA-02-0047-01A	CELSR1	MUT	1.419	1.420	0.016	0.080	N	N/A	N/A	N/A
TCGA-02-2470-01A	CAPN1	MUT	117.302	0.000	0.000	0.024	N	N/A	KEGG_APOPTOSIS,HALLMARK_APOPTOSIS,APOPTOSIS_GO,PROGRAMMED_CELL_DEATH,HALLMARK_ALLOGRAFT_REJECTION,HALLMARK_INTERFERON_GAMMA_RESPONSE,KEGG_PATHWAYS_IN_CANCER,POSITIVE_REGULATION_OF_SIGNAL_TRANSDUCTION,CELL_DEVELOPMENT,HALLMARK_COMPLEMENT	(0.0000000000000002449447873,0.0000000000699407272101932,0.0000000007580872951423148,0.0000000007953914932042285,0.0000000023267710411708236,0.0000000266980328487126158,0.0000000424810473413289463,0.0000000753234439713221658,0.0000001137175443768786276,0.0000002026320538042572718)
TCGA-02-2470-01A	IFNA1	DEL	117.302	0.000	0.000	0.152	N	N/A	KEGG_APOPTOSIS,HALLMARK_APOPTOSIS,APOPTOSIS_GO,PROGRAMMED_CELL_DEATH,HALLMARK_ALLOGRAFT_REJECTION,HALLMARK_INTERFERON_GAMMA_RESPONSE,KEGG_PATHWAYS_IN_CANCER,POSITIVE_REGULATION_OF_SIGNAL_TRANSDUCTION,CELL_DEVELOPMENT,HALLMARK_COMPLEMENT	(0.0000000000000002449447873,0.0000000000699407272101932,0.0000000007580872951423148,0.0000000007953914932042285,0.0000000023267710411708236,0.0000000266980328487126158,0.0000000424810473413289463,0.0000000753234439713221658,0.0000001137175443768786276,0.0000002026320538042572718)
TCGA-02-2470-01A	CDKN2A	DEL	117.302	327.834	0.216	0.416	Y	Dasatinib[http://www.cancerrxgene.org/translation/Drug/51],PD-0332991[http://www.cancerrxgene.org/translation/Drug/1054],WH-4-023[http://www.cancerrxgene.org/translation/Drug/56],AZD-0530[http://www.cancerrxgene.org/translation/Drug/38],Erlotinib[http://www.cancerrxgene.org/translation/Drug/1],BMS-536924[http://www.cancerrxgene.org/translation/Drug/62],WZ-1-84[http://www.cancerrxgene.org/translation/Drug/59],MG-132[http://www.cancerrxgene.org/translation/Drug/9],GNF-2[http://www.cancerrxgene.org/translation/Drug/52],Bortezomib[http://www.cancerrxgene.org/translation/Drug/104],VX-680[http://www.cancerrxgene.org/translation/Drug/32],Imatinib[http://www.cancerrxgene.org/translation/Drug/34],A-770041[http://www.cancerrxgene.org/translation/Drug/55],Paclitaxel[http://www.cancerrxgene.org/translation/Drug/11],AZD6244[http://www.cancerrxgene.org/translation/Drug/1062],AZ628[http://www.cancerrxgene.org/translation/Drug/29],PF-02341066[http://www.cancerrxgene.org/translation/Drug/37],CI-1040[http://www.cancerrxgene.org/translation/Drug/1015],Z-LLNle-CHO[http://www.cancerrxgene.org/translation/Drug/45],GSK269962A[http://www.cancerrxgene.org/translation/Drug/127],Metformin[http://www.cancerrxgene.org/translation/Drug/1000],ZM-447439[http://www.cancerrxgene.org/translation/Drug/1050],Midostaurin[http://www.cancerrxgene.org/translation/Drug/153],Cytarabine[http://www.cancerrxgene.org/translation/Drug/1006],PD-0325901[http://www.cancerrxgene.org/translation/Drug/1060],GSK-650394[http://www.cancerrxgene.org/translation/Drug/177],RDEA119[http://www.cancerrxgene.org/translation/Drug/1014],A-443654[http://www.cancerrxgene.org/translation/Drug/86],SL 0101-1[http://www.cancerrxgene.org/translation/Drug/1039],XMD8-85[http://www.cancerrxgene.org/translation/Drug/106],Sunitinib[http://www.cancerrxgene.org/translation/Drug/5],GW843682X[http://www.cancerrxgene.org/translation/Drug/87],Nutlin-3a[http://www.cancerrxgene.org/translation/Drug/1047],ABT-263[http://www.cancerrxgene.org/translation/Drug/1011],Docetaxel[http://www.cancerrxgene.org/translation/Drug/1007],Sorafenib[http://www.cancerrxgene.org/translation/Drug/30],Lapatinib[http://www.cancerrxgene.org/translation/Drug/119],NVP-BEZ235[http://www.cancerrxgene.org/translation/Drug/1057],Thapsigargin[http://www.cancerrxgene.org/translation/Drug/180]	KEGG_APOPTOSIS,HALLMARK_APOPTOSIS,APOPTOSIS_GO,PROGRAMMED_CELL_DEATH,HALLMARK_ALLOGRAFT_REJECTION,HALLMARK_INTERFERON_GAMMA_RESPONSE,KEGG_PATHWAYS_IN_CANCER,POSITIVE_REGULATION_OF_SIGNAL_TRANSDUCTION,CELL_DEVELOPMENT,HALLMARK_COMPLEMENT	(0.0000000000000002449447873,0.0000000000699407272101932,0.0000000007580872951423148,0.0000000007953914932042285,0.0000000023267710411708236,0.0000000266980328487126158,0.0000000424810473413289463,0.0000000753234439713221658,0.0000001137175443768786276,0.0000002026320538042572718)
TCGA-02-2470-01A	CNTNAP2	MUT	26.386	1.571	0.016	0.088	N	N/A	KEGG_CELL_ADHESION_MOLECULES_CAMS	(0.0011971648023939229169704)
TCGA-02-2470-01A	NFIX	MUT	10.067	0.000	0.000	0.016	N	N/A	TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER	(0.0130656725211634079653056)
TCGA-02-2470-01A	RBBP5	AMPL	7.993	0.000	0.000	0.048	N	N/A	KEGG_ACUTE_MYELOID_LEUKEMIA,KEGG_PATHWAYS_IN_CANCER	(0.0065839370053872494498171,0.0321978006081273249172625)
TCGA-02-2483-01A	FGFR2	AMPL	43.889	0.000	0.000	0.032	Y	PD-173074[http://www.cancerrxgene.org/translation/Drug/1049],A-443654[http://www.cancerrxgene.org/translation/Drug/86]	KEGG_P53_SIGNALING_PATHWAY,BASE_EXCISION_REPAIR	(0.0014155150537679991699924,0.0171001201303383372487321)
TCGA-02-2483-01A	TP53	MUT	43.889	1522.436	0.536	0.536	Y	Nutlin-3a[http://www.cancerrxgene.org/translation/Drug/1047],Thapsigargin[http://www.cancerrxgene.org/translation/Drug/180],Obatoclax Mesylate[http://www.cancerrxgene.org/translation/Drug/182],AZD-2281[http://www.cancerrxgene.org/translation/Drug/1017],AKT inhibitor VIII[http://www.cancerrxgene.org/translation/Drug/171]	KEGG_P53_SIGNALING_PATHWAY,BASE_EXCISION_REPAIR	(0.0014155150537679991699924,0.0171001201303383372487321)
TCGA-02-2485-01A	GLI1	AMPL	38.402	76.623	0.024	0.032	N	N/A	DNA_METABOLIC_PROCESS,BASE_EXCISION_REPAIR,KEGG_P53_SIGNALING_PATHWAY,DNA_REPLICATION	(0.0070407463624783039532473,0.0075443665577456546153523,0.0163501002303827087935861,0.0388252282425850525626743)
TCGA-02-2485-01A	TP53	MUT	38.402	1522.436	0.536	0.536	Y	Nutlin-3a[http://www.cancerrxgene.org/translation/Drug/1047],Thapsigargin[http://www.cancerrxgene.org/translation/Drug/180],Obatoclax Mesylate[http://www.cancerrxgene.org/translation/Drug/182],AZD-2281[http://www.cancerrxgene.org/translation/Drug/1017],AKT inhibitor VIII[http://www.cancerrxgene.org/translation/Drug/171]	DNA_METABOLIC_PROCESS,BASE_EXCISION_REPAIR,KEGG_P53_SIGNALING_PATHWAY,DNA_REPLICATION	(0.0070407463624783039532473,0.0075443665577456546153523,0.0163501002303827087935861,0.0388252282425850525626743)
TCGA-02-2486-01A	ATR	MUT	134.882	0.000	0.000	0.040	Y	N/A	KEGG_APOPTOSIS,KEGG_PATHWAYS_IN_CANCER,KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,I_KAPPAB_KINASE_NF_KAPPAB_CASCADE,POSITIVE_REGULATION_OF_I_KAPPAB_KINASE_NF_KAPPAB_CASCADE,KEGG_PANCREATIC_CANCER,REGULATION_OF_I_KAPPAB_KINASE_NF_KAPPAB_CASCADE,KEGG_CHRONIC_MYELOID_LEUKEMIA,KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY,POSITIVE_REGULATION_OF_SIGNAL_TRANSDUCTION	(0.0000000000000000000160378,0.0000000000000003589673712,0.0000000000000005859485124,0.0000000000001010322609955,0.0000000000012648083429962,0.0000000000044151164150478,0.0000000000044151164150478,0.0000000000065201999548750,0.0000000000140910808431254,0.0000000000186044837289041)
TCGA-02-2486-01A	CDKN2A	DEL	134.882	327.834	0.216	0.416	Y	Dasatinib[http://www.cancerrxgene.org/translation/Drug/51],PD-0332991[http://www.cancerrxgene.org/translation/Drug/1054],WH-4-023[http://www.cancerrxgene.org/translation/Drug/56],AZD-0530[http://www.cancerrxgene.org/translation/Drug/38],Erlotinib[http://www.cancerrxgene.org/translation/Drug/1],BMS-536924[http://www.cancerrxgene.org/translation/Drug/62],WZ-1-84[http://www.cancerrxgene.org/translation/Drug/59],MG-132[http://www.cancerrxgene.org/translation/Drug/9],GNF-2[http://www.cancerrxgene.org/translation/Drug/52],Bortezomib[http://www.cancerrxgene.org/translation/Drug/104],VX-680[http://www.cancerrxgene.org/translation/Drug/32],Imatinib[http://www.cancerrxgene.org/translation/Drug/34],A-770041[http://www.cancerrxgene.org/translation/Drug/55],Paclitaxel[http://www.cancerrxgene.org/translation/Drug/11],AZD6244[http://www.cancerrxgene.org/translation/Drug/1062],AZ628[http://www.cancerrxgene.org/translation/Drug/29],PF-02341066[http://www.cancerrxgene.org/translation/Drug/37],CI-1040[http://www.cancerrxgene.org/translation/Drug/1015],Z-LLNle-CHO[http://www.cancerrxgene.org/translation/Drug/45],GSK269962A[http://www.cancerrxgene.org/translation/Drug/127],Metformin[http://www.cancerrxgene.org/translation/Drug/1000],ZM-447439[http://www.cancerrxgene.org/translation/Drug/1050],Midostaurin[http://www.cancerrxgene.org/translation/Drug/153],Cytarabine[http://www.cancerrxgene.org/translation/Drug/1006],PD-0325901[http://www.cancerrxgene.org/translation/Drug/1060],GSK-650394[http://www.cancerrxgene.org/translation/Drug/177],RDEA119[http://www.cancerrxgene.org/translation/Drug/1014],A-443654[http://www.cancerrxgene.org/translation/Drug/86],SL 0101-1[http://www.cancerrxgene.org/translation/Drug/1039],XMD8-85[http://www.cancerrxgene.org/translation/Drug/106],Sunitinib[http://www.cancerrxgene.org/translation/Drug/5],GW843682X[http://www.cancerrxgene.org/translation/Drug/87],Nutlin-3a[http://www.cancerrxgene.org/translation/Drug/1047],ABT-263[http://www.cancerrxgene.org/translation/Drug/1011],Docetaxel[http://www.cancerrxgene.org/translation/Drug/1007],Sorafenib[http://www.cancerrxgene.org/translation/Drug/30],Lapatinib[http://www.cancerrxgene.org/translation/Drug/119],NVP-BEZ235[http://www.cancerrxgene.org/translation/Drug/1057],Thapsigargin[http://www.cancerrxgene.org/translation/Drug/180]	KEGG_APOPTOSIS,KEGG_PATHWAYS_IN_CANCER,KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,I_KAPPAB_KINASE_NF_KAPPAB_CASCADE,POSITIVE_REGULATION_OF_I_KAPPAB_KINASE_NF_KAPPAB_CASCADE,KEGG_PANCREATIC_CANCER,REGULATION_OF_I_KAPPAB_KINASE_NF_KAPPAB_CASCADE,KEGG_CHRONIC_MYELOID_LEUKEMIA,KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY,POSITIVE_REGULATION_OF_SIGNAL_TRANSDUCTION	(0.0000000000000000000160378,0.0000000000000003589673712,0.0000000000000005859485124,0.0000000000001010322609955,0.0000000000012648083429962,0.0000000000044151164150478,0.0000000000044151164150478,0.0000000000065201999548750,0.0000000000140910808431254,0.0000000000186044837289041)
TCGA-02-2486-01A	IFNA1	DEL	134.882	0.000	0.000	0.152	N	N/A	KEGG_APOPTOSIS,KEGG_PATHWAYS_IN_CANCER,KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,I_KAPPAB_KINASE_NF_KAPPAB_CASCADE,POSITIVE_REGULATION_OF_I_KAPPAB_KINASE_NF_KAPPAB_CASCADE,KEGG_PANCREATIC_CANCER,REGULATION_OF_I_KAPPAB_KINASE_NF_KAPPAB_CASCADE,KEGG_CHRONIC_MYELOID_LEUKEMIA,KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY,POSITIVE_REGULATION_OF_SIGNAL_TRANSDUCTION	(0.0000000000000000000160378,0.0000000000000003589673712,0.0000000000000005859485124,0.0000000000001010322609955,0.0000000000012648083429962,0.0000000000044151164150478,0.0000000000044151164150478,0.0000000000065201999548750,0.0000000000140910808431254,0.0000000000186044837289041)
TCGA-06-0122-01A	CYP19A1	MUT	92.880	0.000	0.000	0.000	N	N/A	KEGG_LEISHMANIA_INFECTION,HALLMARK_ALLOGRAFT_REJECTION,IMMUNE_SYSTEM_PROCESS,HALLMARK_INTERFERON_GAMMA_RESPONSE,KEGG_CHEMOKINE_SIGNALING_PATHWAY,KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION,HALLMARK_KRAS_SIGNALING_UP,DEFENSE_RESPONSE,KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY,HALLMARK_TNFA_SIGNALING_VIA_NFKB	(0.0000000728508814770022898,0.0000391631660289689520352,0.0001617907856008210033035,0.0010535177620062975960974,0.0047367814415559183691129,0.0055903242342797932959431,0.0126297610747109941009558,0.0197607356115705387611392,0.0228101620385382300448818,0.0301031393665559497685447)
TCGA-06-0122-01A	EGFR	AMPL	11.879	352.698	0.112	0.112	Y	BIBW2992[http://www.cancerrxgene.org/translation/Drug/1032],Bosutinib[http://www.cancerrxgene.org/translation/Drug/1019]	N/A	N/A
TCGA-06-0122-01A	LRP1	MUT	11.879	0.000	0.000	0.096	N	N/A	N/A	N/A
TCGA-06-0122-01A	APH1A	MUT	2.490	0.000	0.000	0.120	N	N/A	N/A	N/A
TCGA-06-0122-01A	TTN	MUT	2.200	1662.774	0.624	0.624	N	N/A	STRUCTURAL_CONSTITUENT_OF_MUSCLE,STRIATED_MUSCLE_CONTRACTION_GO_0006941,SARCOMERE,MYOFIBRIL,STRUCTURAL_MOLECULE_ACTIVITY,CONTRACTILE_FIBER_PART,CONTRACTILE_FIBER	(0.0000394003524614167037585,0.0040878226487615831538647,0.0074927539627462954457959,0.0154341620000586175753821,0.0172685635137047772957875,0.0215578619575202967695304,0.0262061173364548267994412)
TCGA-06-0122-01A	TNKS	AMPL	2.183	3.234	0.072	0.104	N	N/A	N/A	N/A
TCGA-06-0122-01A	CDKN2A	DEL	1.533	327.834	0.216	0.416	Y	Dasatinib[http://www.cancerrxgene.org/translation/Drug/51],PD-0332991[http://www.cancerrxgene.org/translation/Drug/1054],WH-4-023[http://www.cancerrxgene.org/translation/Drug/56],AZD-0530[http://www.cancerrxgene.org/translation/Drug/38],Erlotinib[http://www.cancerrxgene.org/translation/Drug/1],BMS-536924[http://www.cancerrxgene.org/translation/Drug/62],WZ-1-84[http://www.cancerrxgene.org/translation/Drug/59],MG-132[http://www.cancerrxgene.org/translation/Drug/9],GNF-2[http://www.cancerrxgene.org/translation/Drug/52],Bortezomib[http://www.cancerrxgene.org/translation/Drug/104],VX-680[http://www.cancerrxgene.org/translation/Drug/32],Imatinib[http://www.cancerrxgene.org/translation/Drug/34],A-770041[http://www.cancerrxgene.org/translation/Drug/55],Paclitaxel[http://www.cancerrxgene.org/translation/Drug/11],AZD6244[http://www.cancerrxgene.org/translation/Drug/1062],AZ628[http://www.cancerrxgene.org/translation/Drug/29],PF-02341066[http://www.cancerrxgene.org/translation/Drug/37],CI-1040[http://www.cancerrxgene.org/translation/Drug/1015],Z-LLNle-CHO[http://www.cancerrxgene.org/translation/Drug/45],GSK269962A[http://www.cancerrxgene.org/translation/Drug/127],Metformin[http://www.cancerrxgene.org/translation/Drug/1000],ZM-447439[http://www.cancerrxgene.org/translation/Drug/1050],Midostaurin[http://www.cancerrxgene.org/translation/Drug/153],Cytarabine[http://www.cancerrxgene.org/translation/Drug/1006],PD-0325901[http://www.cancerrxgene.org/translation/Drug/1060],GSK-650394[http://www.cancerrxgene.org/translation/Drug/177],RDEA119[http://www.cancerrxgene.org/translation/Drug/1014],A-443654[http://www.cancerrxgene.org/translation/Drug/86],SL 0101-1[http://www.cancerrxgene.org/translation/Drug/1039],XMD8-85[http://www.cancerrxgene.org/translation/Drug/106],Sunitinib[http://www.cancerrxgene.org/translation/Drug/5],GW843682X[http://www.cancerrxgene.org/translation/Drug/87],Nutlin-3a[http://www.cancerrxgene.org/translation/Drug/1047],ABT-263[http://www.cancerrxgene.org/translation/Drug/1011],Docetaxel[http://www.cancerrxgene.org/translation/Drug/1007],Sorafenib[http://www.cancerrxgene.org/translation/Drug/30],Lapatinib[http://www.cancerrxgene.org/translation/Drug/119],NVP-BEZ235[http://www.cancerrxgene.org/translation/Drug/1057],Thapsigargin[http://www.cancerrxgene.org/translation/Drug/180]	N/A	N/A
TCGA-06-0124-01A	NCAN	MUT	71.387	0.000	0.000	0.048	N	N/A	KEGG_PATHWAYS_IN_CANCER,KEGG_FOCAL_ADHESION,BASEMENT_MEMBRANE,KEGG_SMALL_CELL_LUNG_CANCER,KEGG_ECM_RECEPTOR_INTERACTION,EXTRACELLULAR_MATRIX_PART,EXTRACELLULAR_REGION,EXTRACELLULAR_REGION_PART,BASAL_LAMINA,PROTEINACEOUS_EXTRACELLULAR_MATRIX	(0.0000000017344025230402556,0.0000011533319334570373152,0.0000016133753735239409207,0.0000187495791225799485202,0.0000204045916245418642958,0.0000306010922909224770657,0.0002810721912787708665071,0.0003851139710973177092586,0.0004804426193097588904286,0.0005927937302650544693083)
TCGA-06-0124-01A	VCAN	MUT	61.809	0.000	0.000	0.080	N	N/A	HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,KEGG_ECM_RECEPTOR_INTERACTION,KEGG_FOCAL_ADHESION,KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC,KEGG_SMALL_CELL_LUNG_CANCER,KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM,KEGG_DILATED_CARDIOMYOPATHY,INTEGRIN_COMPLEX,RESPONSE_TO_EXTERNAL_STIMULUS,RECEPTOR_COMPLEX	(0.0000000006594062389707131,0.0000000010448310870670319,0.0000547768091850549251952,0.0000645693739682723355771,0.0001294171761018687893171,0.0001294171761018687893171,0.0002107689268083455763451,0.0002270045260894892435836,0.0084468742221828815169848,0.0236131623029517782874631)
TCGA-06-0124-01A	EGFR	AMPL	58.325	352.698	0.112	0.112	Y	BIBW2992[http://www.cancerrxgene.org/translation/Drug/1032],Bosutinib[http://www.cancerrxgene.org/translation/Drug/1019]	KEGG_APOPTOSIS,KEGG_PATHWAYS_IN_CANCER,I_KAPPAB_KINASE_NF_KAPPAB_CASCADE,POSITIVE_REGULATION_OF_I_KAPPAB_KINASE_NF_KAPPAB_CASCADE,REGULATION_OF_I_KAPPAB_KINASE_NF_KAPPAB_CASCADE,KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION,KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY,HALLMARK_APOPTOSIS,KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,POSITIVE_REGULATION_OF_SIGNAL_TRANSDUCTION	(0.0000000000135610858780613,0.0000000000160247990557232,0.0000016941667207815166388,0.0000056492775901349845264,0.0000107263879367987687811,0.0001053712911622818029691,0.0001172088708076567028496,0.0001175133011253005687691,0.0001231674097551429918063,0.0001231674097551429918063)
TCGA-06-0124-01A	SMARCA2	MUT	58.325	0.424	0.016	0.128	N	N/A	KEGG_APOPTOSIS,KEGG_PATHWAYS_IN_CANCER,I_KAPPAB_KINASE_NF_KAPPAB_CASCADE,POSITIVE_REGULATION_OF_I_KAPPAB_KINASE_NF_KAPPAB_CASCADE,REGULATION_OF_I_KAPPAB_KINASE_NF_KAPPAB_CASCADE,KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION,KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY,HALLMARK_APOPTOSIS,KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,POSITIVE_REGULATION_OF_SIGNAL_TRANSDUCTION	(0.0000000000135610858780613,0.0000000000160247990557232,0.0000016941667207815166388,0.0000056492775901349845264,0.0000107263879367987687811,0.0001053712911622818029691,0.0001172088708076567028496,0.0001175133011253005687691,0.0001231674097551429918063,0.0001231674097551429918063)
TCGA-06-0124-01A	IFNA1	DEL	58.325	0.000	0.000	0.152	N	N/A	KEGG_APOPTOSIS,KEGG_PATHWAYS_IN_CANCER,I_KAPPAB_KINASE_NF_KAPPAB_CASCADE,POSITIVE_REGULATION_OF_I_KAPPAB_KINASE_NF_KAPPAB_CASCADE,REGULATION_OF_I_KAPPAB_KINASE_NF_KAPPAB_CASCADE,KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION,KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY,HALLMARK_APOPTOSIS,KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,POSITIVE_REGULATION_OF_SIGNAL_TRANSDUCTION	(0.0000000000135610858780613,0.0000000000160247990557232,0.0000016941667207815166388,0.0000056492775901349845264,0.0000107263879367987687811,0.0001053712911622818029691,0.0001172088708076567028496,0.0001175133011253005687691,0.0001231674097551429918063,0.0001231674097551429918063)
TCGA-06-0124-01A	KLHL9	DEL	3.270	24.136	0.120	0.168	N	N/A	N/A	N/A
TCGA-06-0124-01A	CDKN2A	DEL	1.938	327.834	0.216	0.416	Y	Dasatinib[http://www.cancerrxgene.org/translation/Drug/51],PD-0332991[http://www.cancerrxgene.org/translation/Drug/1054],WH-4-023[http://www.cancerrxgene.org/translation/Drug/56],AZD-0530[http://www.cancerrxgene.org/translation/Drug/38],Erlotinib[http://www.cancerrxgene.org/translation/Drug/1],BMS-536924[http://www.cancerrxgene.org/translation/Drug/62],WZ-1-84[http://www.cancerrxgene.org/translation/Drug/59],MG-132[http://www.cancerrxgene.org/translation/Drug/9],GNF-2[http://www.cancerrxgene.org/translation/Drug/52],Bortezomib[http://www.cancerrxgene.org/translation/Drug/104],VX-680[http://www.cancerrxgene.org/translation/Drug/32],Imatinib[http://www.cancerrxgene.org/translation/Drug/34],A-770041[http://www.cancerrxgene.org/translation/Drug/55],Paclitaxel[http://www.cancerrxgene.org/translation/Drug/11],AZD6244[http://www.cancerrxgene.org/translation/Drug/1062],AZ628[http://www.cancerrxgene.org/translation/Drug/29],PF-02341066[http://www.cancerrxgene.org/translation/Drug/37],CI-1040[http://www.cancerrxgene.org/translation/Drug/1015],Z-LLNle-CHO[http://www.cancerrxgene.org/translation/Drug/45],GSK269962A[http://www.cancerrxgene.org/translation/Drug/127],Metformin[http://www.cancerrxgene.org/translation/Drug/1000],ZM-447439[http://www.cancerrxgene.org/translation/Drug/1050],Midostaurin[http://www.cancerrxgene.org/translation/Drug/153],Cytarabine[http://www.cancerrxgene.org/translation/Drug/1006],PD-0325901[http://www.cancerrxgene.org/translation/Drug/1060],GSK-650394[http://www.cancerrxgene.org/translation/Drug/177],RDEA119[http://www.cancerrxgene.org/translation/Drug/1014],A-443654[http://www.cancerrxgene.org/translation/Drug/86],SL 0101-1[http://www.cancerrxgene.org/translation/Drug/1039],XMD8-85[http://www.cancerrxgene.org/translation/Drug/106],Sunitinib[http://www.cancerrxgene.org/translation/Drug/5],GW843682X[http://www.cancerrxgene.org/translation/Drug/87],Nutlin-3a[http://www.cancerrxgene.org/translation/Drug/1047],ABT-263[http://www.cancerrxgene.org/translation/Drug/1011],Docetaxel[http://www.cancerrxgene.org/translation/Drug/1007],Sorafenib[http://www.cancerrxgene.org/translation/Drug/30],Lapatinib[http://www.cancerrxgene.org/translation/Drug/119],NVP-BEZ235[http://www.cancerrxgene.org/translation/Drug/1057],Thapsigargin[http://www.cancerrxgene.org/translation/Drug/180]	N/A	N/A
TCGA-06-0124-01A	EBF2	MUT	1.125	0.124	0.016	0.056	N	N/A	N/A	N/A
